John Sentz, DO
Pulmonary Disease · Richmond, VANPI 1497074561
Payments from drug & device makers
Across 623 payments — averaging $31.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$6K
- Intuitive Surgical$5K
- GSK$2K
- Amgen$679
- Actelion Pharmaceuticals US, Inc.$621
- Grifols USA, LLC$601
- plus $5K from 31 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 63 | $5,789 |
| Intuitive Surgical | 9 | $4,805 |
| GSK | 175 | $1,776 |
| Amgen | 35 | $679 |
| Actelion Pharmaceuticals US, Inc. | 23 | $621 |
| Grifols USA, LLC | 26 | $601 |
| Boehringer Ingelheim | 33 | $549 |
| Regeneron Healthcare Solutions, Inc. | 24 | $533 |
| Mallinckrodt Hospital Products Inc. | 15 | $460 |
| Genentech USA, Inc. | 30 | $452 |
| Sanofi | 26 | $447 |
| Insmed, Inc. | 23 | $353 |
| Mylan Specialty L.p. | 22 | $307 |
| ANI Pharmaceuticals, Inc. | 10 | $306 |
| Novartis | 19 | $295 |
| United Therapeutics Corporation | 15 | $274 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $220 |
| Pfizer | 11 | $212 |
| Electromed, Inc. | 12 | $153 |
| Merck | 7 | $148 |
| Bayer | 6 | $110 |
| Inogen, Inc. | 3 | $64 |
| Sanofi-aventis U.S. LLC | 1 | $57 |
| Teva Pharmaceuticals USA, Inc. | 4 | $55 |
| Philips North America LLC | 3 | $47 |
| Baxter Healthcare | 2 | $42 |
| Covidien LP | 3 | $40 |
| Mallinckrodt Enterprises LLC | 2 | $36 |
| Paratek Pharmaceuticals, Inc. | 2 | $27 |
| Atricure, Inc. | 1 | $26 |
| La Jolla Pharmaceutical Company | 2 | $24 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Covis Pharma GmbH | 1 | $17 |
| Vifor Pharma, Inc. | 1 | $16 |
| Viatris Specialty LLC | 1 | $16 |
| Pulmonx Corporation | 1 | $14 |
| Sandoz | 1 | $12 |
How this compares
$19,604 in reported general payments places this provider in the 80th percentile of 317 pulmonary disease providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Richmond
- Shilpa JohriRichmond$1.7M
- Patricia SimeRichmond$572K
- Apostolos PerelasRichmond$567K
- Ray ShepherdRichmond$303K
- Sujoy GillRichmond$296K
- Glenn GiesselRichmond$267K
- Marjolein DewitRichmond$214K
- Nauman ChaudaryRichmond$77K
- Ritsu KunoRichmond$64K
- Daniel GrinnanRichmond$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.